catalyst

Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia — primary completion

as of 2026-07-01
at a glance
2011-03 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia — primary completion
Type
Trial Readout
Date
2011-03
Date type
ACTUAL
Phase
Phase 2
This event happened.